SGMO: Sangamo Therapeutics, Inc. Stock

by  •  • Comments Off on SGMO: Sangamo Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 108.31
Enterprise Value ($M) 63.11
Book Value ($M) 82.89
Book Value / Share 0.40
Price / Book 1.31
NCAV ($M) 11.89
NCAV / Share 0.06
Price / NCAV 9.11

Profitability (mra)
Return on Invested Capital (ROIC) -2.13
Return on Assets (ROA) -0.59
Return on Equity (ROE) -0.77

Liquidity (mrq)
Quick Ratio 1.98
Current Ratio 1.98

Balance Sheet (mrq) ($M)
Current Assets 94.33
Assets 165.32
Liabilities 82.43
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 176.23
Operating Income -102.49
Net Income -257.83
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -224.84
Cash from Investing 153.53
Cash from Financing 14.59

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-05 13G/A Wasatch Advisors Inc
02-13 13G/A Vanguard Group Inc 7.10 -10.30
02-12 13G/A Biogen Inc. 8.26 -40.00
01-26 13G/A BlackRock Inc. 7.90 -8.23
01-22 13G/A State Street Corp 1.53 -72.33

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K _______________________________________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHAN
2023-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 306,648 1,097,922 27.93
2024-05-02 163,931 727,936 22.52
2024-05-01 526,388 215,453 244.32
2024-04-30 287,257 189,644 151.47
2024-04-29 441,362 125,268 352.33

(click for more detail)

Similar Companies
SANA – Sana Biotechnology, Inc. SCPH – scPharmaceuticals Inc.
SDGR – Schrödinger, Inc. SLDB – Solid Biosciences Inc.
SLRN – Acelyrin, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Sangamo BioSciences